Dr. Thomas Bachleitner-Hofmann is a leading surgical oncologist in Austria, specializing in translational cancer research. As one of the top surgical oncologists in Austria, he focuses on improving perioperative chemotherapy and immunotherapy responses for metastatic cancer patients undergoing curative cancer surgery. His expertise spans colorectal, appendiceal, gastric, and ovarian cancers, along with peritoneal surface malignancies, making him a famous oncologist in Austria. Affiliated with the Medical University of Vienna, he manages crucial clinical databases, including the Peritoneal Surface Malignancy Register and the CRC Tumor Bank, both vital to translational cancer research. As a Principal Investigator, he has led groundbreaking research projects on chemotherapy response prediction, the MET oncogene in colorectal cancer, and innovative cancer treatments. His multidimensional approach combines clinical expertise and advanced research, contributing significantly to the field of curative cancer surgery and positioning him as a leading cancer researcher in Europe.
Dr. Thomas Bachleitner-Hofmann specializes in treating a wide range of oncological and surgical conditions, establishing himself as one of the best cancer surgeons in Austria. His expertise includes breast tumour surgery, abdominal wall hernia repair, benign soft tissue tumour removal, and oesophagal burn treatment, making him a leading oncologist in Vienna. With extensive experience in minimally invasive and robotic surgery, he provides advanced, patient-centred cancer treatment, ensuring optimal surgical outcomes. Recognized as a top robotic surgery specialist, he utilizes precision medicine and innovative therapies to enhance patient care. As a popular hernia surgeon in Austria, his proficiency in complex surgical interventions has earned him a reputation for minimally invasive cancer treatment and high success rates. Patients seek his expertise for both cancer surgery and complex soft tissue tumour removal, benefiting from his specialized approach and commitment to excellence.